Inside the Healthcare Overhaul: HCA's Payer Headwinds and Novartis's Pipeline PushGlobal Report·5 hours agoHCA+1.51%NVS-0.72%
Micro-Cap Purges and Industrial Pivots: The Hidden Overhaul Sweeping Through Q2Global Report·1 day ago, 04:13 AMET-0.29%ROK+0.33%
Tech Pivots to Cloud Mega-Deals as AI Momentum Spills Into BiopharmaGlobal Report·Jul 22 at 04:17 AMAKAM-1.70%GENB-3.11%
Novartis: Buy Rating Reiterated on Q2 Beat, Strong Growth Brands and Pipeline Upside; Price Target Maintained at $140Tip Ranks·Jul 21 at 07:10 PMNVS-0.72%
Novartis AG Stock (NVS) Moved Up by 3.42% on Jul 21: Key Drivers UnveiledTradingKey·Jul 21 at 11:19 AMNVS-0.72%
Novartis CEO shrugs off oral PCSK9 threat amid Q2 growthFiercepharma·Jul 21 at 09:43 AMNVS-0.72%MRK+0.45%
Novartis rises 5% in regular trading as Q2 earnings beat estimatesUS Stock Market Update·Jul 21 at 09:21 AMNVS-0.72%
Novartis Silences Generic Fears With Blowout Quarter, Packed Pipelinebenzinga_article·Jul 21 at 07:21 AMNVS-0.72%
Novartis Q2 Profit Drops 19% Despite Sales Growth; Reaffirms FY26 Outlookrttnews·Jul 21 at 06:15 AMNVS-0.72%
Options Volatility and Implied Earnings Moves Today, July 21, 2026Tip Ranks·Jul 21 at 06:05 AMGM+2.44%MMM+1.79%
